Kit ELISA Carcino Embryonic Antigen sandwich (Hu CEA) (human): quantitative determination of Hu CEA in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu CEA.
Kit ELISA Carcino Embryonic Antigen sandwich (Hu CEA) (human): quantitative determination of Hu CEA in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu CEA.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
The carcinoembryonic antigen Cde66e (CEA) is synthesized in the fetus intestine during development and is again expressed in higher amounts in intestinal carcinomas and several other tumours. The CEA is a member of the family of immunoglobulin supergens, carcinoembryonic antigens, and consists of a single domain N (structural homology on the variable d-immunoglobulin) and six domains of constant-type immunoglobulin A (A1, A2, A3) and B (B1, B2, B3). The ACE antibodies are useful in identifying the origin of the various metastatic adenocarcinomas and distinguishing between pulmonary adenocarcinomas (60-70% are CEA+) and pleural mesotheliomas (rarely or weakly CEA+). CEA is part of the large glycoprotein family, a tumour marker useful for adenocarcinoma, and found in the epithelium adenocarcinomas of the digestive system derived from lhe endoderma and the colon of the foetus. Two subgroups of the CEA family, CEA cell adhesion molecules and pregnancy-specific glycoproteins, are located in a 1.2 Mb group on the long arm of chromosome 19. Eleven pseudogenes from the CEA cell adhesion molecules subgroup are also present in the group. CEA was initially described in the liver bile canals as biliary glycoprotein. Subsequently, it was shown that CEA is a cell adhesion molecule detected on leukocytes, l'épithelium, and l'endothelium. The coded protein allows cell adhesion to be mediated by homophilic bonding and heterophilic bonding to other proteins in the subgroup. Several cellular activities were attributed to coded protein, including roles in differentiation and arrangement of the three-dimensional structure of tissues, Several transcription variants coding different isoforms were recorded, but the full length nature of all variants was not defined.
Sensitivity
Sensitivity of the dosage: 200 pg/ml.
Measurement range
Dose range: 0.343-250 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Intradose variation coefficient < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15464943 |
| Specifications |
| Accession number | P06731 |
| Dose range | 0.343-250 ng/ml |
| Sensitivity of the dosage | 200 pg/ml |
| Calibration range | 0.2 ng/ml to 250 ng/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Cell structure & organic proteins |
| Type of sample | Serum, Surnatant, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the following tested cytokines: human angiogenin, BDNF, BLC, ENA-78, FGF- 4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN-gamma, leptin ( |
| Sufficient for | 96 dosages |
| Target species | Human |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 1048 |
| Gene symbol(s) | CD66e,CEA |
| Coefficient of inter-dose variation | < 12 % |
| Coefficient of intra-dose variation | < 10 % |
| Contents of kits | 96-well pre-coated plate, Standard, Dose diluent concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Research disciplines | Extracellular Matrix & Cell Adhesion |
| Synonym | CD66e, CEA |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; serum, 50 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EHCEA |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.